|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2002-10-31
|
|
pubmed:abstractText |
To study the effect of antiretroviral combination treatment on intrathecal immunoactivation in HIV-1 infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
8
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2145-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12409735-Adult,
pubmed-meshheading:12409735-Anti-HIV Agents,
pubmed-meshheading:12409735-Drug Combinations,
pubmed-meshheading:12409735-Female,
pubmed-meshheading:12409735-HIV Infections,
pubmed-meshheading:12409735-Humans,
pubmed-meshheading:12409735-Male,
pubmed-meshheading:12409735-Middle Aged,
pubmed-meshheading:12409735-Neopterin,
pubmed-meshheading:12409735-RNA, Viral,
pubmed-meshheading:12409735-Viral Load,
pubmed-meshheading:12409735-beta 2-Microglobulin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Göteborg University, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
